Genixcure Signs MOU with Modalis for Joint Development of AAV Gene Therapy Using Proprietary AAV Vector
Genixcure Inc.(CEO Hong-Sung Moon), a company specializing in AI-based AAV engineering platforms (CARETM), announced that it has signed a strategic memorandum of understanding (MOU) with Modalis Therapeutics Corporation (Modalis, www.modalistx.com), a …